The Complete Good Manufacturing Practices Course [2026]

Explore quality management systems and risk management in pharmaceutical manufacturing, guided by FDA quality system guidance, with quality by design, CAPA, change control, and cross-functional integration for sustainable compliance.

Define and monitor well-defined inputs, ownership, and accountability to ensure robust process design, concise SOPs, effective change control, and ongoing audits within quality systems.

Apply a risk-based approach to pharmaceutical manufacturing with quality risk management, FDA guidance, and tools like risk maps, Q9 framework, HACCP, and HAZOP to protect patients.

Explore management responsibility for cGMP oversight, building a practical pharmaceutical quality system to achieve and maintain a state of control, prevent adulteration, and meet FDA requirements.

Explore the quality management triad model, linking governance, the pharmaceutical quality system, and quality system ownership to ensure cGMP compliance through SOPs, quality unit oversight, and Qmr-driven continuous improvement.

The quality control unit provides essential support with final responsibility for certain manufacturing actions, defines QC and QA roles, and ensures procedures, records, audits, and supplier approvals meet GMP expectations.

examine warning letter citations for the quality control unit under cGMP and outline robust oversight of raw materials, manufacturing, and finished drugs, including contractor oversight and quality agreements.

Identify GMP training system expectations, define qualified personnel and job descriptions, establish organizational charts, and implement ongoing training, evaluation, and documentation to ensure proper task performance.

Curricula define role-based training requirements for all personnel, covering corporate, site, and functional area needs with ongoing GMP and regulatory requirements, including management approvals where appropriate.

Create comprehensive training plans that cover onboarding, job skill training, and ongoing education, with site-specific onboarding, individual and departmental plans, and annual site training reviews to ensure cGMP readiness.

Define training needs through analysis, design content with subject matter experts, and determine delivery and assessments for GMP tasks to meet regulatory expectations.

Qualified trainers, as SMEs with GMP expertise, deliver and assess training, using knowledge- and performance-based methods while management and regulators require qualification evidence and Kirkpatrick-based evaluations.

Understand how GMP training records capture completion, content approvals, curricula, and change control, ensuring traceability, audit proof, and ongoing management oversight of training across the organization.

Compare consultants and contractors in GMP programs, outline training and onboarding requirements, qualification documentation, and oversight to ensure on-site performance aligns with company processes.

Outline the FDA's cGMP requirements for dietary supplements under DSHEA, detailing how manufacturers verify ingredient identity and perform testing, ensure quality and labeling, and follow master manufacturing records.

Explore how homeopathic drugs are regulated under CGMPs, HPUS and USP standards, with FDA 400.400 policy guidance, import/export considerations, and safety protections for vulnerable populations.

Learn how written procedures for production and process control ensure drug identity, strength, quality, and purity, and how SOPs, document control, change control, and deviation investigations support GMP quality systems.

Charge-in of components ensures identity, strength, and purity by weighing, labeling, and verifying each component, ensuring 100% of the labeled active ingredient with second-person checks during dispensing.

Identify and trace equipment, lines, and containers with contents and processing stage using status tags and logbooks, and understand the process validation life cycle from design to continued verification.

Establish and validate hold times for production phases through pilot plant studies and stability testing to preserve quality, ensure stability before processing, and minimize microbial risk.

Validate aseptic processing by sterilizing and depyrogenating components and equipment, and qualify the environment with HEPA-filtered air, particle controls, and barrier technologies to maintain sterility.

Summarizes validation of ethylene oxide sterilization, including temperature, humidity, gas distribution, penetration, lethality, and residue removal due to health hazards, and gamma irradiation validation with cobalt-60 and three dose levels.

Understand FDA's 21 CFR part 11 on electronic records and signatures, system validation, and archiving requirements, plus annual quality reviews and senior management oversight in cGMP.

Record major equipment cleaning and use in dedicated logs, linking each entry to date, time, product, and lot number, to ensure traceability and batch record integrity.

Prepare accurate batch production and control records by reproducing master documents, checking accuracy, and dating with signatures. QC reviews ensure compliance, investigate deviations, and control records to support batch release.

Explore how events, deviations, and investigations drive root-cause analysis, prompt reporting, evidence collection, and corrective actions to protect product quality and regulatory compliance.

Capture detailed observations with date, time, and personnel, then escalate to QA for a formal investigation using root cause analysis and CAPA. Close CAPA timely with effectiveness checks.

Maintain distribution records with product name, strength, dosage description, form, and the concern’s name and address; ensure recalls and audits are supported by timely, accurate records and complaint investigations.

Apply current good manufacturing practices to clinical trial materials, emphasizing documentation, housekeeping, and good scientific practices in CTM manufacturing and packaging.

Apply a cGMP conceptual model to CTM production, detailing quality unit duties, procedures, change control, and cross-contamination controls across clinical development.

Understand CTM manufacturing: equipment management, cleaning validation and qualification, and packaging, labeling, stability, and laboratory controls under cGMP, with deviation handling and stock recovery.

Explore how virtual and multinational pharma companies manage contracting and outsourcing while maintaining cGMP compliance, quality systems, and regulatory expectations across development, manufacturing, and packaging.

Outlines the outsourcing process in cGMP contexts, including needs assessment, contractor identification, RFPs, due diligence, SOPs, quality agreements, audits, ongoing management, and risk control.

Identify and manage other types of contractors for engineering, calibration, and support services, through defined scope, on-site supervision, audits, documentation, and SOPs to ensure cGMP compliance.

Design and construction features for GMP facilities address external and internal environments, site selection, zoning, utilities, unidirectional flow, and storage controls to prevent mix-ups and contamination.

Define adequate lighting for each production area and measure light levels to meet 30–50 foot candles, with levels as needed, and monitor ventilation and air handling for aseptic penicillin production.

Maintain pharmaceutical facilities in good repair to protect product quality. Address cracks, leaks, and pests to prevent contamination and safety hazards, while documenting maintenance and essential services.